90 micron flaps get the thumbs up

Article

Using a femotsecond laser (IntraLase) to create flaps of 90 microns does not increase the postoperative risk of striae formation or induction of optical aberrations.

Using a femotsecond laser (IntraLase) to create flaps of 90 microns does not increase the postoperative risk of striae formation or induction of optical aberrations, according to Omid Kermani and colleagues from Augenklinik am Neumarkt, Cologne, Germany.

A total of 25 eyes (18 patients) were treated with the femtosecond laser, applying an intended thickness of 90 microns. A further 25 eyes (14 patients) received LASIK flap cuts with a conventional microkeratome (MK 2000; Nidek), applying an intended flap thickness of 130 microns. All eyes were treated for myopia or myopic astigmatism with the Nidek EC CXIII refractive excimer laser.

No vision threatening complications occurred in any of the treatments and in all eyes, the flap could be opened and repositioned after laser ablation. Dr Kermani conceded that the 90 micron flaps were slightly more difficult to lift compared with normal femtosecond flaps of 120 microns.

The mean femtosecond flap thickness was 95 microns with a standard deviation of ±10 microns and the mean microkeratome flap thickness was 115 microns with a standard deviation of ±25 microns.

Ninety percent of all eyes (from both groups) were within ±0.5 D of target refraction and one day after LASIK, all eyes had a visual acuity of 0.8 or more. Furthermore, no eyes lost more than one line of best corrected visual acuity.

Dr Kermani concluded that flaps with a thickness below 100 microns were not associated with an increased postoperative risk.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.